Phase II/III clinical trial
Term · Oncology and biomedicine · MLC-T-ONC-006602
A study that tests how well a new treatment works for a certain type of cancer or other disease and compares the new treatment with a standard treatment. Phase II/III clinical trials may also provide more information about the safety and side effects of the new treatment. Combining phases II and III may allow research questions to be answered more quickly or with fewer patients. Also called phase 2/phase 3 clinical trial.
| Identifier | MLC-T-ONC-006602 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | phase 2/phase 3 clinical trial |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-006602",
"term": "Phase II/III clinical trial",
"field": "Oncology and biomedicine",
"definition": "A study that tests how well a new treatment works for a certain type of cancer or other disease and compares the new treatment with a standard treatment. Phase II/III clinical trials may also provide more information about the safety and side effects of the new treatment. Combining phases II and III may allow research questions to be answered more quickly or with fewer patients. Also called phase 2/phase 3 clinical trial.",
"synonyms": [
"phase 2/phase 3 clinical trial"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/phase-ii-iii-clinical-trial/"
}
Record 13,093 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.